PCK1 | Phosphoenolpyruvate carboxykinase 1 (soluble) | Citric acid cycle related proteins Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
PID1 | Phosphotyrosine interaction domain containing 1 | | | | | | Mixed |
PIK3C2A | Phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha | Enzymes
| | | | | Expressed in all |
PIK3CB | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta | Cancer-related genes Enzymes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PPP3CB | Protein phosphatase 3, catalytic subunit, beta isozyme | Enzymes
| | | | | Expressed in all |
PRKAA1 | Protein kinase, AMP-activated, alpha 1 catalytic subunit | Enzymes FDA approved drug targets
| | | | | Expressed in all |
PRKAA2 | Protein kinase, AMP-activated, alpha 2 catalytic subunit | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
PRKCA | Protein kinase C, alpha | Cancer-related genes Enzymes Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
PSMD9 | Proteasome (prosome, macropain) 26S subunit, non-ATPase, 9 | Plasma proteins
| | | | | Expressed in all |
PTPN2 | Protein tyrosine phosphatase, non-receptor type 2 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
PTPRF | Protein tyrosine phosphatase, receptor type, F | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
RAPGEF4 | Rap guanine nucleotide exchange factor (GEF) 4 | | | | | | Tissue enhanced |
RBP4 | Retinol binding protein 4, plasma | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
RELA | V-rel avian reticuloendotheliosis viral oncogene homolog A | Cancer-related genes Disease related genes RAS pathway related proteins Transcription factors
| | | | | Expressed in all |
RFX6 | Regulatory factor X, 6 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
RHEB | Ras homolog enriched in brain | Cancer-related genes
| | | | | Expressed in all |
RPTOR | Regulatory associated protein of MTOR, complex 1 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
SIK2 | Salt-inducible kinase 2 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
SNX15 | Sorting nexin 15 | | | | | | Expressed in all |
SYT8 | Synaptotagmin VIII | Predicted membrane proteins
| | | | | Tissue enhanced |
TCF7L2 | Transcription factor 7-like 2 (T-cell specific, HMG-box) | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
TRIB3 | Tribbles pseudokinase 3 | Enzymes
| | | | | Tissue enhanced |
TSC1 | Tuberous sclerosis 1 | Cancer-related genes Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
UCP2 | Uncoupling protein 2 (mitochondrial, proton carrier) | Mitochondrial proteins Transporters
| | | | | Expressed in all |
UQCC2 | Ubiquinol-cytochrome c reductase complex assembly factor 2 | | | | | | Expressed in all |
VGF | VGF nerve growth factor inducible | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
AR | Androgen receptor | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Tissue enhanced |
ARRB1 | Arrestin, beta 1 | | | | | | Expressed in all |
CPE | Carboxypeptidase E | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DENND4C | DENN/MADD domain containing 4C | Predicted membrane proteins
| | | | | Expressed in all |
DOK5 | Docking protein 5 | | | | | | Tissue enhanced |
EIF2AK3 | Eukaryotic translation initiation factor 2-alpha kinase 3 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
HNF1B | HNF1 homeobox B | Disease related genes Transcription factors
| | | | | Tissue enhanced |
HNF4A | Hepatocyte nuclear factor 4, alpha | Disease related genes Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
HTRA4 | HtrA serine peptidase 4 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
IGF2BP2 | Insulin-like growth factor 2 mRNA binding protein 2 | Cytoskeleton related proteins Plasma proteins
| | | | | Mixed |
IGFBPL1 | Insulin-like growth factor binding protein-like 1 | Predicted secreted proteins
| | | | | Tissue enriched |
IGFL1 | IGF-like family member 1 | Predicted secreted proteins
| | | | | Tissue enriched |
IGFL2 | IGF-like family member 2 | Predicted secreted proteins
| | | | | Group enriched |
IGFL3 | IGF-like family member 3 | Predicted secreted proteins
| | | | | Tissue enriched |
IGFL4 | IGF-like family member 4 | | | | | | Group enriched |
PDK4 | Pyruvate dehydrogenase kinase, isozyme 4 | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
PTPRN | Protein tyrosine phosphatase, receptor type, N | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
PTRF | Polymerase I and transcript release factor | Disease related genes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
RAB10 | RAB10, member RAS oncogene family | | | | | | Expressed in all |
RAB13 | RAB13, member RAS oncogene family | | | | | | Expressed in all |
SLC2A2 | Solute carrier family 2 (facilitated glucose transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SOCS1 | Suppressor of cytokine signaling 1 | Cancer-related genes
| | | | | Mixed |
YWHAG | Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma | Plasma proteins
| | | | | Expressed in all |
AACS | Acetoacetyl-CoA synthetase | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |